1News on Nostr: Pharmac leaves blanket funding for treatment of children with cancer ========== ...
Pharmac leaves blanket funding for treatment of children with cancer
==========
Pharmac has decided to retain blanket funding for the treatment of children with cancer, which will be life-saving for some. The decision brings relief to many families and clinicians. However, some are disappointed that the drug-funding agency did not extend Rule 8.1b to cover all children with life-threatening or chronic diseases. About 150 children are diagnosed with cancer each year, and up to 15 access medicines using Rule 8.1b. Rule 8.1b ensures that every child with cancer receives the same access to life-saving medicines. The decision not to extend the rule to other conditions may be concerning to some, but Pharmac states that the rule was specifically designed for the treatment of pediatric cancers and supports best practices for timely access to medicines and clinical trials. The review of funding for pediatric cancer medicines started in 2019 and came to public attention after a complaint to the Human Rights Tribunal. The complaint alleged discrimination against children who did not have cancer. Advocates are calling for the rule to be extended to cover all children who need life-saving medicines.
#Pharmac #Children #Cancer #Funding #Rule8.1b #Medicine
https://www.1news.co.nz/2024/03/17/pharmac-leaves-blanket-funding-for-treatment-of-children-with-cancer/
==========
Pharmac has decided to retain blanket funding for the treatment of children with cancer, which will be life-saving for some. The decision brings relief to many families and clinicians. However, some are disappointed that the drug-funding agency did not extend Rule 8.1b to cover all children with life-threatening or chronic diseases. About 150 children are diagnosed with cancer each year, and up to 15 access medicines using Rule 8.1b. Rule 8.1b ensures that every child with cancer receives the same access to life-saving medicines. The decision not to extend the rule to other conditions may be concerning to some, but Pharmac states that the rule was specifically designed for the treatment of pediatric cancers and supports best practices for timely access to medicines and clinical trials. The review of funding for pediatric cancer medicines started in 2019 and came to public attention after a complaint to the Human Rights Tribunal. The complaint alleged discrimination against children who did not have cancer. Advocates are calling for the rule to be extended to cover all children who need life-saving medicines.
#Pharmac #Children #Cancer #Funding #Rule8.1b #Medicine
https://www.1news.co.nz/2024/03/17/pharmac-leaves-blanket-funding-for-treatment-of-children-with-cancer/